s-disease

Documents about s-disease

• Immune receptor LAG3 regulates microglia function during Alzheimer’s disease#217724Europe PMC
• Tau-Connectome Predictive Modeling and Subtyping in Preclinical Alzheimer's Disease#256630EliScholar
• Stress, stress systems, and Alzheimer's disease.#265469NCBI PubMed Central
• Structural and functional magnetic resonance imaging abnormalities and plasma GLP-1 levels in Parkinson's disease with cognitive impairment#5357Europe PMC
• Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study#8270HAL (France)
• Unravelling the multi-target mechanism of methoxylated flavonoids in Parkinson's disease: Insights from network pharmacology and molecular dynamics#123357Europe PMC
• Hyphenated Mass Spectrometry-based Strategies for Characterizing Oligomers of alpha-Synuclein in Parkinson’s Disease#241329Yoda MOAI Feed
• Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells#274375HAL (France)
• Amyloid‐related imaging abnormalities (ARIA) in anti‐amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup#125786Europe PMC
• <i>Blautia coccoides</i>-derived metabolite trimethylamine-N-oxide exacerbates Alzheimer's disease progression via targeting HIF1α signaling#5183Europe PMC
• Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance#167578Digital Commons @ University of Georgia School of Law
• Cyclophosphamide-free Mobilisation Increases Safety While Preserving the Efficacy of Autologous Haematopoietic Stem Cell Transplantation in Refractory Crohn&apos;s Disease Patients#226471Dipòsit Digital de la Universitat de Barcelona
• The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review#253598Europe PMC
• Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization#6901OpenAlex
• Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis.#182283NCBI PubMed Central
• Documented End-of-Life Preferences of People With Parkinson's Disease or Parkinsonism Across Europe.#193896PubMed
• Use of machine learning and voice for multiclass classification of Parkinson's disease, chronic obstructive pulmonary disease, and healthy controls.#213975NCBI PubMed Central
• Clinical characteristics and predictors of disease progression in parkinson's disease in a cohort of patients in the ashanti region, Ghana.#267001NCBI PubMed Central
• [Research progress on intelligent brain age prediction methods in diagnosis of Parkinson's disease].#143185NCBI PubMed Central
• History of hypertensive disorders of pregnancy and risk of Alzheimer's disease and vascular dementia.#170527NCBI PubMed Central
• A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease#172990HAL (France)
• An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.#174463NCBI PubMed Central
• Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer's Disease: a Systematic Review of Mechanistic Insights.#182307NCBI PubMed Central
• Blood - brain barrier breakdown and neurovascular unit failure in the progression of Alzheimer's disease.#193520NCBI PubMed Central
• The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma.#3727NCBI PubMed Central
• Alcohol, Cardiovascular Disease, and Industry Influence: A Meta-review#29749bioRxiv / medRxiv
• Blood-based biomarkers of ferroptosis in Parkinson's disease#137370HAL (France)
• Single-Nuclei Transcriptomic Characterization of APOE4-Associated Alzheimer's Disease#151551bioRxiv / medRxiv
• IRF4 haploinsufficiency in a multiplex family with Whipple’s disease#284244HAL (France)
• APOE-ε4 genotype and western diet synergistically aggravate synaptic dysfunction in Alzheimer’s disease via d-serine disruption#7844HAL (France)
• Parkinson’s disease patients treated with fetal tissue are assessed three years after surgery. The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease#167709Apollo
• Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer’s disease#205386Figshare
• The GETAID: over 40 years of academic research in IBD#156303HAL (France)
• The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research.#162235PubMed
• Amping up With PemJAK#249578ClinicalTrials.gov
• Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)#257065ClinicalTrials.gov
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology#273312Europe PMC
• Inflammatory Bowel Disease Patients’ Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis#288104HAL (France)
• Sugarcane Disease Detection Using Deep-Learning and LIME#83716PhilArchive
• Leveraging electronic health records to examine differential clinical outcomes in people with Alzheimer's disease.#146177NCBI PubMed Central
• Reduced inhibition, bursting, and accelerated oscillations drive early hippocampal hyperactivity in Alzheimer's disease in vivo.#220914NCBI PubMed Central
• Integrating stakeholder perspectives in the co-design of medical device software to monitor Parkinson's disease symptoms- A case-study#234986Europe PMC
• Global burden of ischemic heart disease from 1990 to 2021: Findings from the Global Burden of Disease Study 2021 and predictions to 2030.#67518NCBI PubMed Central
• Machine learning combined with WGCNA reveals potential calcium uptake-associated biomarkers in Parkinson's disease.#181845PubMed
• Historical Petrol Lead Emissions and Motor Neuron Disease Mortality in Australia#28637bioRxiv / medRxiv
• Parkinson's Disease Workshop#66787MIT OpenCourseWare
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths.#123059NCBI PubMed Central
• Beyond Rurality: Individual SES and Chronic disease prevalence#152668bioRxiv / medRxiv
• A brain-penetrant P2X7R antagonist mitigates Alzheimer's disease pathology#162286bioRxiv / medRxiv
• Mechanistic learning to predict and understand minimal residual disease.#174544NCBI PubMed Central